We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Zika Vaccine Shows Protective Efficacy in Monkeys

News   Dec 06, 2018 | Original story from the University of Hawai'i at Manoa

 
Zika Vaccine Candidate Effective in Preclinical Trials

Zika virus results in neurological complications in babies born from infected mothers. The immunogenicity and protective efficacy of a recombinant subunit vaccine candidate has been demonstrated in mice, and in long-tailed macaques (Macaca fascicularis, also known as the crab-eating macaque). Image credit: Mr. Theklan.

 
 
 

RELATED ARTICLES

Alzheimer's Trafficking Defect Corrected in Rodents

News

UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.

READ MORE

Immune System Kept in Check by Protein Police

News

Researchers learn how a key transcription factor helps regulate the immune system and could be critical to understanding autoimmune disease and cancer immunosuppression.

READ MORE

How Anti-psychotic Medications Drive Weight Gain

News

About three million Americans take antipsychotic medications for conditions such as bipolar disorder, PTSD and schizophrenia. These medications are vital for mental health, yet many people stop taking them because of the side effects of weight gain and associated metabolic diseases.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE